LIVIVO - Search results -

Search results

Result 1 - 10 of total 44

Search options

Article ; Online: Investigation of the terminal P4 domain in a series of D-phenylglycinamide-based factor Xa inhibitors.

Franciskovich, Jeffry B / Masters, John J / Weber, Wayne W / Klimkowski, Valentine J / Chouinard, Michael / Sipes, Philip R / Johnson, Lea M / Snyder, David W / Chastain, Marcia K / Craft, Trelia J / Towner, Richard D / Gifford-Moore, Donetta S / Froelich, Larry L / Smallwood, Jeffrey K / Foster, Ronald S / Smith, Gerald F / Liebeschuetz, John W / Murray, Christopher W / Young, Stephen C

Bioorganic & medicinal chemistry letters

2007 Volume 17, Issue 24, Page(s) 6910–6913

Abstract: ... synthesized and evaluated for their ability to bind to the serine protease factor Xa. Some of the more potent ... Several P4 domain derivatives of the general d-phenylglycinamide-based scaffold (2) were ...

Abstract	Several P4 domain derivatives of the general d-phenylglycinamide-based scaffold (2) were synthesized and evaluated for their ability to bind to the serine protease factor Xa. Some of the more potent compounds were evaluated for their anticoagulant effects in vitro. A select subset containing various P1 indole constructs was further evaluated for their pharmacokinetic properties after oral administration to rats.
MeSH term(s)	Anticoagulants/chemical synthesis ; Anticoagulants/chemistry ; Anticoagulants/pharmacology ; Antithrombin III/chemical synthesis ; Antithrombin III/chemistry ; Antithrombin III/pharmacology ; Crystallography, X-Ray ; Factor Xa/chemistry ; Factor Xa/metabolism ; Glycine/analogs & derivatives ; Glycine/chemical synthesis ; Glycine/chemistry ; Glycine/pharmacology ; Humans ; Models, Molecular ; Molecular Structure ; Protein Binding ; Structure-Activity Relationship
Chemical Substances	Anticoagulants ; phenylglycinamide ; Antithrombin III (9000-94-6) ; Factor Xa (EC 3.4.21.6) ; Glycine (TE7660XO1C)
Language	English
Publishing date	2007-12-15
Publishing country	England
Document type	Journal Article
ZDB-ID	1063195-1
ISSN	1464-3405 ; 0960-894X
ISSN (online)	1464-3405
ISSN	0960-894X
DOI	10.1016/j.bmcl.2007.09.105
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 3203: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Acute renal syndrome/renal angina: a new paradigm for studies of acute kidney injury?

Johnson, Xa D / Liu, Kathleen D

Clinical journal of the American Society of Nephrology : CJASN

2010 Volume 5, Issue 5, Page(s) 753–755

MeSH term(s)	Acute Disease ; Biomarkers/blood ; Critical Care ; Early Diagnosis ; Health Status Indicators ; Humans ; Kidney/metabolism ; Kidney Diseases/blood ; Kidney Diseases/diagnosis ; Kidney Diseases/etiology ; Kidney Diseases/mortality ; Kidney Diseases/therapy ; Predictive Value of Tests ; Risk Assessment ; Risk Factors ; Syndrome ; Terminology as Topic
Chemical Substances	Biomarkers
Language	English
Publishing date	2010-05
Publishing country	United States
Document type	Comment ; Editorial
ZDB-ID	2226665-3
ISSN	1555-905X ; 1555-9041
ISSN (online)	1555-905X
ISSN	1555-9041
DOI	10.2215/CJN.02360310
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 6584: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Effect of plasma-activated water and buffer solution combined with ultrasound on fungicide degradation and quality of cherry tomato during storage.

Ali, Murtaza / Cheng, Jun-Hu / Tazeddinova, Diana / Aadil, Rana Muhammad / Zeng, Xin-An / Goksen, Gulden / Lorenzo, Jose Manuel / Esua, Okon Johnson / Manzoor, Muhammad Faisal

Ultrasonics sonochemistry

2023 Volume 97, Page(s) 106461

Abstract: The purpose of this study was to examine plasma-activated buffer solution (PABS) and plasma-activated water (PAW) combined with ultrasonication (U) treatment on the reduction of chlorothalonil fungicide and the quality of tomato fruits during storage. To ...

Abstract	The purpose of this study was to examine plasma-activated buffer solution (PABS) and plasma-activated water (PAW) combined with ultrasonication (U) treatment on the reduction of chlorothalonil fungicide and the quality of tomato fruits during storage. To obtain PAW and PABS, an atmospheric air plasma jet was used to treat buffer solution and deionized water at different treatment times (5 and 10 min). For combined treatments, fruits were submerged in PAW and PABS, then sonicated for 15 min, and individual treatment without sonication. As per the results, the maximum chlorothalonil reduction of 89.29% was detected in PAW-U
MeSH term(s)	Water/chemistry ; Fungicides, Industrial ; Solanum lycopersicum ; Nitriles
Chemical Substances	Water (059QF0KO0R) ; tetrachloroisophthalonitrile (J718M71A7A) ; Fungicides, Industrial ; Nitriles
Language	English
Publishing date	2023-05-30
Publishing country	Netherlands
Document type	Journal Article
ZDB-ID	1208333-1
ISSN	1873-2828 ; 1350-4177
ISSN (online)	1873-2828
ISSN	1350-4177
DOI	10.1016/j.ultsonch.2023.106461
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 4441: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: SLC25A51 is a mammalian mitochondrial NAD

Luongo, Timothy S / Eller, Jared M / Lu, Mu-Jie / Niere, Marc / Raith, Fabio / Perry, Caroline / Bornstein, Marc R / Oliphint, Paul / Wang, Lin / McReynolds, Melanie R / Migaud, Marie E / Rabinowitz, Joshua D / Johnson, F Brad / Johnsson, Kai / Ziegler, Mathias / Cambronne, Xiaolu A / Baur, Joseph A

Nature

2020 Volume 588, Issue 7836, Page(s) 174–179

Abstract: Mitochondria require nicotinamide adenine dinucleotide ( ... ...

Abstract	Mitochondria require nicotinamide adenine dinucleotide (NAD
MeSH term(s)	Animals ; Biological Transport ; Cell Line ; Cell Respiration/genetics ; Genetic Complementation Test ; Humans ; Mice ; Mitochondria/genetics ; Mitochondria/metabolism ; Mitochondria/pathology ; Mitochondrial Proteins/deficiency ; Mitochondrial Proteins/genetics ; Mitochondrial Proteins/metabolism ; NAD/metabolism ; Nucleotide Transport Proteins/genetics ; Organic Cation Transport Proteins/deficiency ; Organic Cation Transport Proteins/genetics ; Saccharomyces cerevisiae/cytology ; Saccharomyces cerevisiae/genetics ; Saccharomyces cerevisiae/metabolism ; Saccharomyces cerevisiae Proteins/genetics
Chemical Substances	Mitochondrial Proteins ; Ndt1 protein, S cerevisiae ; Nucleotide Transport Proteins ; Organic Cation Transport Proteins ; Saccharomyces cerevisiae Proteins ; NAD (0U46U6E8UK)
Language	English
Publishing date	2020-09-09
Publishing country	England
Document type	Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
ZDB-ID	120714-3
ISSN	1476-4687 ; 0028-0836
ISSN (online)	1476-4687
ISSN	0028-0836
DOI	10.1038/s41586-020-2741-7
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 26: Show issues			Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG)
Zs.MG 9: Show issues
Zs.MO 244: Show issues

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: The use of betrixaban for extended prophylaxis of venous thromboembolism events in hospitalized, high-risk patients.

Dobesh, Paul P / Ahuja, Tania / Davis, George A / Fatodu, Hugh / Francis, William H / Hull, Frank P / Johnson, Gary L / Lenchus, Joshua D / Lenoir, Jacqueline Glee / McPherson, Claudette / Nemeth, Jeffrey / Riello, Ralph J

The American journal of managed care

2018 Volume 24, Issue 22 Suppl, Page(s) S475–S482

MeSH term(s)	Acute Disease ; Aged ; Benzamides/administration & dosage ; Benzamides/therapeutic use ; Factor Xa Inhibitors/administration & dosage ; Factor Xa Inhibitors/therapeutic use ; Female ; Health Care Costs ; Hospitalization ; Humans ; Male ; Primary Prevention ; Pyridines/administration & dosage ; Pyridines/therapeutic use ; Randomized Controlled Trials as Topic ; Risk Factors ; United States/epidemiology ; Venous Thromboembolism/epidemiology ; Venous Thromboembolism/prevention & control
Chemical Substances	Benzamides ; Factor Xa Inhibitors ; Pyridines ; betrixaban (74RWP7W0J9)
Language	English
Publishing date	2018-11-19
Publishing country	United States
Document type	Journal Article ; Research Support, Non-U.S. Gov't
ZDB-ID	2035781-3
ISSN	1936-2692 ; 1088-0224 ; 1096-1860
ISSN (online)	1936-2692
ISSN	1088-0224 ; 1096-1860
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 5353: Show issues			Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG)
Zs.MG 86: Show issues

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Oral anticoagulation is preferable to injected, but only if it is safe and effective: An interview study of patient and carer experience of oral and injected anticoagulant therapy for cancer-associated thrombosis in the select-d trial.

Hutchinson, Ann / Rees, Sophie / Young, Annie / Maraveyas, Anthony / Date, Kathryn / Johnson, Miriam J

Palliative medicine

2018 Volume 33, Issue 5, Page(s) 510–517

Abstract: ... benefit of thrombosis treatment.: Design: Qualitative substudy of the select-d trial, using semi ... of low-molecular-weight heparin. The 'select-d' trial is an open-label, randomised, multi-centre pilot trial in patients ...

Abstract	Background: Cancer patients have a four- to fivefold greater risk of thrombosis than the general population. Recommended treatment for cancer-associated thrombosis is 3-6 months of low-molecular-weight heparin. The 'select-d' trial is an open-label, randomised, multi-centre pilot trial in patients with cancer-associated thrombosis, utilising dalteparin (low-molecular-weight heparin) versus rivaroxaban (a direct oral anticoagulant), to assess effectiveness and safety. Aim: To explore patient and informal carers' experiences of cancer-associated thrombosis and their experience and understanding of the risk-benefit of thrombosis treatment. Design: Qualitative substudy of the select-d trial, using semi-structured interviews. Interviews were audio-recorded and transcribed. Data were analysed using Framework Analysis. Participants: Participants were purposively sampled ( n = 37 patients; 46% male; age 40-89; 9 with carer present). Results: Three themes were found: experience of cancer-associated thrombosis, experience of anticoagulation and risk-benefit balance of the two modes of administration. Some were shocked by their thrombosis diagnosis (most were unaware of their risk), but others found it insignificant compared with cancer. Most patients found tablets more convenient, but injections were acceptable in the context of having cancer. While most were happy to follow medical advice, others weighed preference on the basis of effectiveness. Conclusion: Lack of awareness of thrombosis risk is concerning; cancer patients must be informed to enable prompt help-seeking. Tablets could provide a welcome choice for patients if there is equivalent risk-benefit to injected anticoagulants. Patients trust their clinicians to tailor their treatment. Future research could explore the effect of routine information giving about the risk of thrombosis.
MeSH term(s)	Administration, Oral ; Adult ; Aged ; Aged, 80 and over ; Anticoagulants/administration & dosage ; Dalteparin/administration & dosage ; Factor Xa Inhibitors/administration & dosage ; Female ; Humans ; Injections ; Male ; Middle Aged ; Neoplasms/complications ; Patient Satisfaction ; Rivaroxaban/administration & dosage ; Venous Thrombosis/prevention & control
Chemical Substances	Anticoagulants ; Factor Xa Inhibitors ; Rivaroxaban (9NDF7JZ4M3) ; Dalteparin (S79O08V79F)
Language	English
Publishing date	2018-11-29
Publishing country	England
Document type	Journal Article ; Multicenter Study ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't
ZDB-ID	639247-7
ISSN	1477-030X ; 0269-2163
ISSN (online)	1477-030X
ISSN	0269-2163
DOI	10.1177/0269216318815377
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 2285: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Best practices for implementing venous thromboembolism prophylaxis across the continuum of care.

The American journal of managed care

2018 Volume 24, Issue 22 Suppl, Page(s) S483–S488

MeSH term(s)	Anticoagulants/therapeutic use ; Benzamides/therapeutic use ; Factor Xa Inhibitors/therapeutic use ; Hospitalization ; Humans ; Primary Prevention ; Pyridines/therapeutic use ; Risk Assessment/methods ; Risk Factors ; Transitional Care/standards ; United States ; Venous Thromboembolism/prevention & control
Chemical Substances	Anticoagulants ; Benzamides ; Factor Xa Inhibitors ; Pyridines ; betrixaban (74RWP7W0J9)
Language	English
Publishing date	2018-11-19
Publishing country	United States
Document type	Journal Article ; Research Support, Non-U.S. Gov't
ZDB-ID	2035781-3
ISSN	1936-2692 ; 1088-0224 ; 1096-1860
ISSN (online)	1936-2692
ISSN	1088-0224 ; 1096-1860
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 5353: Show issues			Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG)
Zs.MG 86: Show issues

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Synthesis, Binding Mode, and Antihyperglycemic Activity of Potent and Selective (5-Imidazol-2-yl-4-phenylpyrimidin-2-yl)[2-(2-pyridylamino)ethyl]amine Inhibitors of Glycogen Synthase Kinase 3.

Journal of medicinal chemistry

2017 Volume 60, Issue 20, Page(s) 8482–8514

Abstract: In an effort to identify new antidiabetic agents, we have discovered a novel family of (5-imidazol-2-yl-4-phenylpyrimidin-2-yl)[2-(2-pyridylamino)ethyl]amine analogues which are inhibitors of human glycogen synthase kinase 3 (GSK3). We developed ... ...

Abstract	In an effort to identify new antidiabetic agents, we have discovered a novel family of (5-imidazol-2-yl-4-phenylpyrimidin-2-yl)[2-(2-pyridylamino)ethyl]amine analogues which are inhibitors of human glycogen synthase kinase 3 (GSK3). We developed efficient synthetic routes to explore a wide variety of substitution patterns and convergently access a diverse array of analogues. Compound 1 (CHIR-911, CT-99021, or CHIR-73911) emerged from an exploration of heterocycles at the C-5 position, phenyl groups at C-4, and a variety of differently substituted linker and aminopyridine moieties attached at the C-2 position. These compounds exhibited GSK3 IC
MeSH term(s)	Animals ; CHO Cells ; Chromatography, High Pressure Liquid ; Cricetulus ; Crystallography, X-Ray ; Enzyme Inhibitors/chemical synthesis ; Enzyme Inhibitors/metabolism ; Enzyme Inhibitors/pharmacology ; Glycogen Synthase Kinases/antagonists & inhibitors ; Humans ; Hypoglycemic Agents/chemical synthesis ; Hypoglycemic Agents/metabolism ; Hypoglycemic Agents/pharmacology ; Mass Spectrometry ; Proton Magnetic Resonance Spectroscopy ; Pyrimidines/chemistry ; Pyrimidines/metabolism ; Pyrimidines/pharmacology ; Rats ; Structure-Activity Relationship
Chemical Substances	Enzyme Inhibitors ; Hypoglycemic Agents ; Pyrimidines ; Glycogen Synthase Kinases (EC 2.7.11.-)
Language	English
Publishing date	2017-10-10
Publishing country	United States
Document type	Journal Article ; Research Support, Non-U.S. Gov't
ZDB-ID	218133-2
ISSN	1520-4804 ; 0022-2623
ISSN (online)	1520-4804
ISSN	0022-2623
DOI	10.1021/acs.jmedchem.7b00922
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.B 151: Show issues			Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG)
Zs.MB 1: Show issues

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Crystal structure of the prothrombinase complex from the venom of Pseudonaja textilis.

Lechtenberg, Bernhard C / Murray-Rust, Thomas A / Johnson, Daniel J D / Adams, Ty E / Krishnaswamy, Sriram / Camire, Rodney M / Huntington, James A

Blood

2013 Volume 122, Issue 16, Page(s) 2777–2783

Abstract: The prothrombinase complex, composed of the protease factor (f)Xa and cofactor fVa, efficiently ...

Abstract	The prothrombinase complex, composed of the protease factor (f)Xa and cofactor fVa, efficiently converts prothrombin to thrombin by specific sequential cleavage at 2 sites. How the complex assembles and its mechanism of prothrombin processing are of central importance to human health and disease, because insufficient thrombin generation is the root cause of hemophilia, and excessive thrombin production results in thrombosis. Efforts to determine the crystal structure of the prothrombinase complex have been thwarted by the dependence of complex formation on phospholipid membrane association. Pseutarin C is an intrinsically stable prothrombinase complex preassembled in the venom gland of the Australian Eastern Brown Snake (Pseudonaja textilis). Here we report the crystal structures of the fX-fV complex and of activated fXa from P textilis venom and the derived model of active pseutarin C. Structural analysis supports a single substrate binding channel on fVa, to which prothrombin and the intermediate meizothrombin bind in 2 different orientations, providing insight into the architecture and mechanism of the prothrombinase complex-the molecular engine of blood coagulation.
MeSH term(s)	Animals ; Binding Sites ; Blood Coagulation ; Crystallography, X-Ray ; Elapid Venoms/chemistry ; Factor V/chemistry ; Factor Xa/chemistry ; Humans ; Models, Molecular ; Mutation ; Protein Conformation ; Protein Structure, Tertiary ; Snake Venoms/enzymology ; Snakes ; Thromboplastin/chemistry
Chemical Substances	Elapid Venoms ; Pseutarin C ; Snake Venoms ; prothrombinase complex ; Factor V (9001-24-5) ; Thromboplastin (9035-58-9) ; Factor Xa (EC 3.4.21.6)
Language	English
Publishing date	2013-07-18
Publishing country	United States
Document type	Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
ZDB-ID	80069-7
ISSN	1528-0020 ; 0006-4971
ISSN (online)	1528-0020
ISSN	0006-4971
DOI	10.1182/blood-2013-06-511733
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Uh III Zs.140: Show issues			Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG)
Zs.MO 364: Show issues

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article: Antithrombin-S195A factor Xa-heparin structure reveals the allosteric mechanism of antithrombin activation.

Johnson, Daniel J D / Li, Wei / Adams, Ty E / Huntington, James A

The EMBO journal

2006 Volume 25, Issue 9, Page(s) 2029–2037

Abstract: ... IXa and Xa. Here we present the crystallographic structure of the recognition (Michaelis) complex ...

Abstract	Regulation of blood coagulation is critical for maintaining blood flow, while preventing excessive bleeding or thrombosis. One of the principal regulatory mechanisms involves heparin activation of the serpin antithrombin (AT). Inhibition of several coagulation proteases is accelerated by up to 10,000-fold by heparin, either through bridging AT and the protease or by inducing allosteric changes in the properties of AT. The anticoagulant effect of short heparin chains, including the minimal AT-specific pentasaccharide, is mediated exclusively through the allosteric activation of AT towards efficient inhibition of coagulation factors (f) IXa and Xa. Here we present the crystallographic structure of the recognition (Michaelis) complex between heparin-activated AT and S195A fXa, revealing the extensive exosite contacts that confer specificity. The heparin-induced conformational change in AT is required to allow simultaneous contacts within the active site and two distinct exosites of fXa (36-loop and the autolysis loop). This structure explains the molecular basis of protease recognition by AT, and the mechanism of action of the important therapeutic low-molecular-weight heparins.
MeSH term(s)	Allosteric Regulation ; Animals ; Antithrombin III/antagonists & inhibitors ; Antithrombin III/chemistry ; Crystallography ; Factor Xa/chemistry ; Factor Xa/genetics ; Fibrinolytic Agents/chemistry ; Fibrinolytic Agents/pharmacology ; Heparin/chemistry ; Heparin/pharmacology ; Humans ; Protein Conformation
Chemical Substances	Fibrinolytic Agents ; Antithrombin III (9000-94-6) ; Heparin (9005-49-6) ; Factor Xa (EC 3.4.21.6)
Language	English
Publishing date	2006-04-13
Publishing country	England
Document type	Journal Article ; Research Support, Non-U.S. Gov't
ZDB-ID	586044-1
ISSN	1460-2075 ; 0261-4189
ISSN (online)	1460-2075
ISSN	0261-4189
DOI	10.1038/sj.emboj.7601089
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.A 1808: Show issues			Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG)
Zs.MG 100: Show issues

Order via subito

Details ▾

To top

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito